Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of obesity medicine
The race to launch a pill for weight loss
Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of obesity medicine